BlackRock: "Tokenization Offers Greater Growth Opportunities Than Virtual Asset ETFs"
Robby Mitchnik, Head of Digital Assets: "Expecting Further Growth for Bitcoin"
"Expansion of Income-Generating ETFs… Plans for Selective Expansion of ETFs Going Forward"
[Edaily Reporter Lee Jeong Hun ] BlackRock, the world’s largest asset manager, forecasts additional growth opportunities in the Bitcoin and cryptocurrency investment product markets. However, the firm predicts that tokenization will present greater growth opportunities than the successful cryptocurrency spot exchange-traded funds (ETFs).
Robbie Michnick, Head of Digital Assets at BlackRock
Robbie Michnik, Head of Digital Assets at BlackRock, stated in an interview with Anthony Pompliano on the 19th (local time) that the firm plans to selectively expand its Bitcoin and cryptocurrency investment products in response to growing demand from institutional investors.
According to him, while the price of Bitcoin has risen 30% since June 30, artificial intelligence (AI)-related stocks have fallen 20%. This indicates that the correlation between Bitcoin and AI-related stocks is weakening. Analysts suggest that this shift enhances Bitcoin’s appeal as a diversification tool within investment portfolios and could attract additional investment capital.
Mitchnik explained that concerns over rising government debt, fiscal deficits, and currency depreciation are driving increased investor interest in Bitcoin. He predicted that these concerns would intensify as high interest rates persist, increasing the government’s interest burden on its debt.
Traditionally, gold has been used as a primary hedge against currency instability. However, Michnik noted that more investors are now considering Bitcoin as an alternative. He explained that while Bitcoin is more volatile than gold, it is viewed as an asset with correspondingly higher upside potential.
Michnik noted that BlackRock’s iShares Bitcoin Trust ETF (IBIT) has been steadily attracting investors despite 13 months of subdued market sentiment. He explained that the minimum transaction size required to convert Bitcoin into an ETF has been lowered from $30 million to $1 million. He further analyzed that benefits in terms of taxation, estate and inheritance planning, and trading convenience are also supporting demand for ETF investments.
Michnik particularly emphasized that BlackRock is expanding its business scope into income-generating investment products utilizing Bitcoin and Ethereum.
However, he stressed that BlackRock will maintain a cautious and selective product launch strategy based on actual investor demand, rather than indiscriminately releasing new products.
Michnik predicted that, in the long term, tokenization would offer greater business opportunities than virtual asset ETFs. He noted that tokenizing traditional financial assets—such as stocks and bonds—on the blockchain could draw significant capital into on-chain financial markets.
In particular, tokenization can offer several advantages over traditional financial markets. He cited 24-hour trading, instant settlement and clearing, and broader market accessibility as key examples. He predicted that these characteristics would facilitate the migration of traditional financial assets to the blockchain, thereby creating new growth opportunities.
Michnik predicted that regulatory uncertainty surrounding cryptocurrencies in the U.S. and legislative delays regarding the CLARITY Act (Virtual Asset Market Structure Act) would have a limited impact on BlackRock’s digital asset business strategy. He cited the fact that a certain level of regulatory clarity has already been established for Bitcoin and Ethereum as the basis for this view.
Based on this, BlackRock plans to expand its virtual asset investment products to meet the demand of institutional investors, while also seeking growth opportunities in the tokenization market for traditional financial assets in the long term.
BlackRock, the world’s largest asset manager, forecasts additional growth opportunities in the Bitcoin and cryptocurrency investment product markets. However, the firm predicts that tokenization will …
Mezzion Pharma Co., Ltd.(140410)has overturned a rejection decision that had been blocking the registration of a U.S. patent for the use of Udenafil in the treatment of liver disease. The company plan…
(Graphic: ChatGPT)
Celltrion(068270)’s European subsidiaries have secured supply contracts one after another in procurement tenders conducted by local hospitals and pharmaceutical purchasing organ…